The U.S. Food and Drug Administration (FDA) has licensed the first of its kind live attenuated nasal spray influenza vaccine that can be administered at home. Adults up to the age 49 will be eligible to self-administer the FluMist Home vaccine or give it to their children two to 17 years old as long as they have a prescription.1
The intranasal vaccine, FluMist, manufactured by AstraZeneca, was licensed in 2003 for people aged five through 49, but the license was modified in 2007 to include children as young as two years of age. The pharmaceutical giant has contracted with a third-party on-line pharmacy to distribute the at-home intra-nasal vaccine. Patients will undergo a screening and if they meet the criteria will receive a prescription for the vaccine which will be mailed directly to their home.2
Despite the pharmaceutical company providing data in hopes of having the vaccine available to be administered at home for this flu season, the FDA did not license it in time so FluMist Home will not be available until next flu season.3 4
…
Read Full Article Here…(thevaccinereaction.org)
Home | Caravan to Midnight (zutalk.com)
Live Stream + Chat (zutalk.com)
